Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 WuXi PharmaTech Tox Site Certified by SFDA | Contract Pharma

What are you searching for?

Sign in
Breaking News

WuXi PharmaTech Tox Site Certified by SFDA

WuXi PharmaTech has been awarded a certificate of Good Laboratory Practice (GLP) compliance for its toxicology facility in Suzhou, from the State Food and Drug Administration (SFDA), China's regulatory authority.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

WuXi PharmaTech has been awarded a certificate of Good Laboratory Practice (GLP) compliance for its toxicology facility in Suzhou, from the State Food and Drug Administration (SFDA), China’s regulatory authority.

The certification covers single-dose and multiple-dose toxicology studies in both rodents and non-rodents, GeneTox studies, and toxicokinetic studies, and was issued following the SFDA’s review of WuXi’s management, personnel, test facilities, standard operating procedures, and study operations.

“This certificate from the SFDA is an important milestone in offering our clients toxicology studies that meet both domestic and international GLP quality standards for filing INDs both in China and other countries,” said Dr. Ge Li, chairman and chief executive officer of WuXi PharmaTech. “With this award, WuXi moves a step closer to achieving its goal of offering our pharmaceutical and biotech clients a comprehensive, fully integrated platform of pharmaceutical R&D services.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics